RayKnowChina Research Map
Shortlist

Cancer

Hepatocellular carcinoma in Chengdu

成都 肝细胞癌

All diseases in Chengdu

5 hospitals in Chengdu

Order: papers led on hepatocellular carcinoma, 2021–2025, then A–Z. Research activity, not a rating of care.

Only hospitals listed for hepatocellular carcinoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Chengdu may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.

  1. 392 papers led
  2. 42 papers led
    No open trial led
  3. 30 papers led
    No open trial led
  4. 19 papers led
  5. 8 papers led
    No open trial led

Hepatocellular carcinoma in every city Chengdu on the disease page, with the national map

26

open trials on hepatocellular carcinoma with a hospital in Chengdu

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with a listed hospital in Chengdu as lead sponsor or study site. 17 of them are led by a hospital in Chengdu. Check the registry for the current status. Whether someone can take part is decided by the study team.

Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.

  1. Recruiting
    NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
    Phase
    Early phase 1
    Started
    2026-01
    Registry
    NCT07295262

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  2. Recruiting
    Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
    Phase
    Not given
    Started
    2026-03
    Registry
    NCT07295275

    Age 18 years to 80 years (registered criteria)

    Led by West China Hospital; 2 listed hospitals as study sitesBeijing, Chengdu, Xuzhou

  3. Recruiting
    Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
    Phase
    Not given
    Started
    2026-01
    Registry
    NCT07295340

    Age 18 years to 80 years (registered criteria)

    Led by West China HospitalChengdu

  4. Recruiting
    Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma
    Phase
    Not given
    Started
    2026-03
    Registry
    NCT07410715

    Age 18 years to 80 years (registered criteria)

    Led by West China HospitalChengdu

  5. Recruiting
    PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
    Phase
    Phase 2
    Started
    2026-04
    Registry
    NCT07463248

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  6. Recruiting
    A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
    Phase
    Phase 1/Phase 2
    Started
    2026-02
    Registry
    NCT07482059

    Age 18 years to 80 years (registered criteria)

    Led by West China HospitalChengdu

  7. Recruiting
    Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
    Phase
    Not given
    Started
    2025-04
    Registry
    NCT06950827

    Age 18 years to Not stated (registered criteria)

    Led by West China HospitalChengdu

  8. Recruiting
    PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
    Phase
    Phase 1
    Started
    2025-10
    Registry
    NCT07053072

    Age 18 years to 70 years (registered criteria)

    Led by West China HospitalChengdu

  9. Recruiting
    Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
    Phase
    Phase 1
    Started
    2025-08
    Registry
    NCT07077356

    Age 18 years to Not stated (registered criteria)

    Led by West China HospitalChengdu

  10. Recruiting
    A Study of GV20-0251 in Advanced or Refractory Solid Tumors
    Phase
    Phase 1
    Started
    2025-09
    Registry
    NCT07106827

    Age 18 years to Not stated (registered criteria)

    Led by West China HospitalChengdu

  11. Recruiting
    Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
    Phase
    Not given
    Started
    2025-09
    Registry
    NCT07170345

    Age 18 years to 18 years (registered criteria)

    Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Chengdu, Fuzhou, Guangzhou, Nanning, Shanghai, Shenyang, Wenzhou, Zhengzhou, Zhuhai

  12. Recruiting
    Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
    Phase
    Phase 1
    Started
    2025-11
    Registry
    NCT07176650

    Age 18 years to 65 years (registered criteria)

    Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Bengbu, Changchun, Chengdu, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xi'an, Zhengzhou

  13. Recruiting
    ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
    Phase
    Phase 2
    Started
    2025-06
    Registry
    NCT07327034

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 39 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guilin, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Shenyang, Tianjin, Wuhan, Xi'an, Xuzhou, Yinchuan, Zhengzhou

  14. Recruiting
    Phase 2 Study of WGI-0301 for Advanced HCC
    Phase
    Phase 2
    Started
    2024-07
    Registry
    NCT06309485

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesChangsha, Chengdu, Hangzhou, Harbin, Nanchang, Wuhan

  15. Recruiting
    A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
    Phase
    Phase 1/Phase 2
    Started
    2024-07
    Registry
    NCT06427941

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 16 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanchang, Nanning, Shijiazhuang, Wenzhou, Wuhan, Xuzhou

  16. Recruiting
    TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
    Phase
    Phase 3
    Started
    2024-08
    Registry
    NCT06485466

    Age 18 years to 80 years (registered criteria)

    Led by Sichuan Cancer HospitalChengdu

  17. Recruiting
    PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
    Phase
    Phase 2
    Started
    2024-10
    Registry
    NCT06742424

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  18. Recruiting
    Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
    Phase
    Phase 3
    Started
    2023-05
    Registry
    NCT05862337

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 43 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Jinan, Lanzhou, Luzhou, Nanchang, Nanchong, Nanning, Nantong, Ningbo, Shanghai, Shenyang, Taizhou, Tianjin, Urumqi, Wenzhou, Xi'an, Zhengzhou

  19. Recruiting
    Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
    Phase
    N/A
    Started
    2023-12
    Registry
    NCT06219096

    Age 18 years to 75 years (registered criteria)

    Led by West China HospitalChengdu

  20. Recruiting
    CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
    Phase
    Phase 1
    Started
    2023-10
    Registry
    NCT06560827

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou

  21. Recruiting
    Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
    Phase
    Phase 1/Phase 2
    Started
    2022-12
    Registry
    NCT05652920

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 6 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Hangzhou, Shanghai

  22. Not yet recruiting
    Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma.
    Phase
    Not given
    Started
    2027-01
    Registry
    NCT07912853

    Age 18 years to Not stated (registered criteria)

    Led by West China HospitalChengdu

  23. Not yet recruiting
    Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
    Phase
    Phase 3
    Started
    2026-01
    Registry
    NCT07356037

    Age 18 years to 85 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteChengdu

  24. Not yet recruiting
    Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC
    Phase
    N/A
    Started
    2026-04
    Registry
    NCT07480382

    Age 18 years to 80 years (registered criteria)

    Led by West China HospitalChengdu

  25. Not yet recruiting
    YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
    Phase
    Phase 1
    Started
    2026-07
    Registry
    NCT07580261

    Age 18 years to 70 years (registered criteria)

    Led by West China HospitalChengdu

  26. Not yet recruiting
    Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma
    Phase
    N/A
    Started
    2026-12
    Registry
    NCT07866612

    Age 18 years to 80 years (registered criteria)

    Led by West China Hospital; 8 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Shanghai

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Disease research in Chengdu

Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.

A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.

Papers led and open trials led by hospitals in Chengdu, by disease
CancerBlood disordersOther diseases
HospitalNasopharyngeal carcinomaOesophageal squamous cell carcinomaHepatocellular carcinomaStomach cancerHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMultiple myelomaB-cell acute lymphoblastic leukaemiaAplastic anaemiaHaemophagocytic lymphohistiocytosisBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNeuromyelitis optica spectrum disorderIgG4-related diseaseMyasthenia gravisMoyamoya diseaseWilson diseaseBiliary atresiaAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiencyShortlist
Affiliated Cancer Hospital of Chengdu Medical College成都市第七人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Hospital of Chengdu University成都大学附属医院7none3014nonenone15nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone8none3nonenonenonenone2nonenonenonenonenone2nonenonenonenonenonenonenonenonenonenone
Affiliated Hospital of Southwest Jiao Tong University成都市第三人民医院nonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Hospital of Southwest Jiaotong University成都市第三人民医院nonenonenonenonenonenone1none4nonenonenonenonenonenone11nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Sport Hospital of Chengdu Sport University成都体育学院附属体育医院nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Affiliated Women's and Children's Hospital of Chengdu Medical College四川省妇幼保健院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Eighth People's Hospital成都市第八人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Fifth People's Hospital成都市第五人民医院nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu First People's Hospital成都市中西医结合医院nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Jinniu District People's Hospital成都市金牛区人民医院nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Qingbaijiang District People's Hospital成都市青白江区人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Second People's Hospital成都市第二人民医院nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Seventh People's Hospital成都市第七人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Chengdu Third People's Hospital成都市第三人民医院nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children's Central Hospital, University of Electronic Science成都市妇女儿童中心医院nonenonenonenone1nonenonenonenone1nonenonenonenonenonenone1nonenonenonenonenonenonenonenonenone2nonenone1none1nonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children'S Central Hospital, University of Electronic Science成都市妇女儿童中心医院nonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Children's Hospital, University of Electronic Science成都市妇女儿童中心医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital of Chengdu Medical College成都医学院第一附属医院nonenone86none2none1nonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenone14nonenonenonenonenonenone1none1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Fourth Hospital of Sichuan University四川大学华西医学中心nonenonenonenonenonenonenonenonenone1nonenonenonenone2nonenonenonenonenonenonenonenonenone5nonenonenonenone1none2nonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Fourth Hospital of SichuanUniversity四川大学华西医学中心nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Gastrointestinal Cancer Centre华西-牛津消化道肿瘤研究中心nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenone
Hua Xi Hospital, Sichuan University四川大学华西医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Huaxi Hospital, Sichuan University四川大学华西医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
People's Liberation Army The General Hospital中国人民解放军西部战区总医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sciences Sichuan Translational Medicine Research Hospital中国科学院四川转化医学研究医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Second Affiliated Hospital of Chengdu Medical College成都医学院第二附属医院(核工业四一六医院)nonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan Cancer Hospital四川省肿瘤医院252 open501 open191 open13nonenonenone031nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan People's Hospital四川省人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan Province People's Hospital四川省人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenone
Sichuan Provincial Hospital四川省人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Sichuan Provincial People's Hospital四川省人民医院354224nonenone1632none13nonenonenonenone01nonenone7none2nonenonenone201017none5nonenonenonenone11101 opennonenonenone011nonenone11nonenonenonenone
Sichuan Taikang Hospital四川泰康医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Third People's Hospital, Chongqing Medical University成都市第三人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Third People's Hospital, The Second Clinical Medical College of Chongqing Medical University成都市第三人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
West China Hospital四川大学华西医院442 open716 open39216 open1684 open413363352 open959141224none2136111611none72231431260152262340none011351420nonenonenonenone
West China Hospital of Stomatology四川大学华西口腔医院1nonenonenonenonenonenone5none1nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenone1nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenone
West China Second University Hospital四川大学华西第二医院nonenonenonenone1nonenone1131none23721nonenonenonenonenone0nonenone451none21120021011nonenone2nonenone31nonenonenonenonenonenonenone
West China Sencond Hospital四川大学华西第二医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
West China Teaching Hospital四川大学华西第四医院nonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Xindu District People's Hospital成都市新都区人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

Column labels are short names. Choose one to open that disease in Chengdu.

Other cities nearby

Straight-line distance from the city centre; counts are hospitals listed for hepatocellular carcinoma.

Counts are listed hospitals only, not every hospital in each city.

Where these numbers come from

Papers

English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions

Trials

ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Chengdu on ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data